NEUROGENE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.96 USD | +0.30% |
|
-1.74% | +54.59% |
| 03-22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
| 03-21 | William Blair Initiates Neurogene With Outperform Rating | MT |
Chart calendar Neurogene Inc.
577e1b4c3380223c7b74227.9tVxUK_hO_oW71m8a1Qr91zPIfi4sQeAugUpNMRMfPc.nLhIOcyADb1ijjrSPgB7sCmgEc3S1XPkj0ltbLMrScOmpRAo3KZDmHe4bQ~e3248ae36ca43679034f22594eb9c3a1
Upcoming events on Neurogene Inc.
Past events on Neurogene Inc.
| 20/03/2024 13:30 | Stifel CNS Day |
| 18/03/2024 20:14 | Q4 2023 Earnings Release |
| 10/03/2024 | Leerink Partners Global Biopharma Conference |
| 05/03/2024 15:30 | TD Cowen Health Care Conference |
| 18/07/2023 13:30 | Neoleukin Therapeutics, Inc. and Neurogene Inc. Merger Call |
| 08/06/2023 21:30 | Annual General Meeting |
| 09/05/2023 20:42 | Q1 2023 Earnings Release |
| 12/12/2022 17:45 | American Society of Hematology Meeting - Publication Number: 684 |
| 14/11/2022 21:03 | Q3 2022 Earnings Release |
| 10/08/2022 18:00 | Canaccord Growth Conference |
| 09/08/2022 21:30 | Interim 2022 Earnings Call |
| 09/08/2022 21:02 | Interim 2022 Earnings Release |
| 25/05/2022 17:30 | H.C. Wainwright Global Life Sciences Investment Conference |
| 12/05/2022 21:30 | Annual General Meeting |
| 11/05/2022 21:20 | Bank of America Healthcare Conference |
| 09/05/2022 21:05 | Q1 2022 Earnings Release |
| 14/04/2022 17:00 | Canaccord Horizons in Oncology Virtual Conference |
| 13/04/2022 15:00 | American Association of Cancer Research Meeting - Abstract No 4227 |
| 13/04/2022 15:00 | American Association of Cancer Research Meeting - Abstract No CT250 |
| 11/04/2022 19:30 | American Association of Cancer Research Meeting - Abstract No 2067 |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -55,6 -56,3 1.33% | -65,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -36,3 -53,6 32.24% | -59,2 |
|
Net income Million USD | Released Forecast Spread | -55,2 | -36,3 -53,9 32.58% | -66,9 |
|
EPS USD | Released Forecast Spread | -10,6 | -7,80 -5,58 -39.84% | -3,62 |
| Announcement Date | 08/11/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,7 -15,5 4.64% | -15,3 | -15,9 | -16,6 | -17,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2,38 -14,9 116% | -13,8 | -14,4 | -15,1 | -15,9 |
|
Net income Million USD | Released Forecast Spread | 2,38 -15,1 115.75% | -17,1 | -15,7 | -16,7 | -17,7 |
|
EPS USD | Released Forecast Spread | -1,17 | -1,00 | -0,91 | -0,95 | -0,86 |
| Announcement Date | 18/03/24 | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Neurogene Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NGNE Stock
- Calendar Neurogene Inc.
